HCM FY 2018 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$214M-11.2% YoY

Gross Profit

$70M32.8% margin

Operating Income

-$93M-43.3% margin

Net Income

-$75M-34.9% margin

EPS (Diluted)

$-0.55

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$39M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$532M

Total Liabilities

$120M

Stockholders' Equity

$389M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$214M	$241M	-11.2%
Gross Profit	$70M	$65M	+7.3%
Operating Income	-$93M	-$53M	-73.4%
Net Income	-$75M	-$27M	-179.8%